 "Dr Lal PathLabs Q1FY25 results: Net profit rises 28% to Rs 106 cr")
Dr Lal PathLabs on Wednesday said its consolidated profit after tax increased 29 per cent to Rs 108 crore for the first quarter ending June 30, 2024.
The company had reported a profit after tax of Rs 84 crore in the April-June quarter of the last fiscal.
Revenue rose to Rs 602 crore for the period under review as compared to Rs 541 crore in the June quarter of last fiscal, Dr Lal PathLabs said in a statement.
The company said its board has approved an interim dividend of Rs 6 per share for 2024-25.
Shares of the company on Wednesday ended 3.17 per cent up at Rs 3,268.85 apiece on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app